Valsartan: Difference between revisions
(Links) |
Elcatracho (talk | contribs) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 23: | Line 23: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*Angioedema | *[[Angioedema]] | ||
*Acute renal failure | *[[Acute renal failure]] | ||
===Common=== | ===Common=== | ||
*Hypotension | *Hypotension | ||
| Line 42: | Line 43: | ||
==See Also== | ==See Also== | ||
*[[Hypertension]] | |||
*[[Angiotensin II receptor antagonists]] | |||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Cardiology]] | |||
Latest revision as of 16:06, 8 March 2021
Administration
- Type: Angiotensin II receptor antagonists
- Dosage Forms:
- Routes of Administration: oral
- Common Trade Names: Diovan
Adult Dosing
- 20-160mg PO 1-2 times per day
Pediatric Dosing
Safety/efficacy not established
Special Populations
- Pregnancy Rating: D
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing: no adjustment
- Hepatic dosing: no adjustment
Contraindications
- Allergy to class/drug
- Concomitant aliskiren use in diabetic patients
Adverse Reactions
Serious
Common
- Hypotension
- Dizziness, headache
- Elevated BUN/Cr
- Cough
Pharmacology
- Half-life: 6h
- Metabolism:
- Excretion: Mostly fecal
Mechanism of Action
- Angiotensin II antagonist